-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Sigilon Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q2 2023.
- Sigilon Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$7.51M, a 47.7% increase year-over-year.
- Sigilon Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$30.3M, a 54.2% increase year-over-year.
- Sigilon Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$43.6M, a 43.6% increase from 2021.
- Sigilon Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$77.3M, a 41.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)